China Biotech Services (8037.HK) and National Institute for Viral Disease Control and Prevention (NIVDC) to develop Genetically Engineered Recombinant Vaccine for COVID-19
HONG KONG, Oct 5, 2020 – (ACN Newswire) – China Biotech Services Holdings (CBSH; 8037.HK)…
PLN Reaffirms Commitment to Advancing a Just Energy Transition at COP30
Kyrgyz Republic Launches First Issuance of Gold-Backed Stablecoin USDKG
OMP Miami Conference 2025: Transforming Supply Chain Vision into REAL Impact with Human-AI Synergy
Doubleview Gold Corp. Highlights Scandium Potential at Hat Project, a Key Enabler for the Electrification Economy
U.S. Polo Assn. Receives Multiple Global Honors Recognizing Excellence in Brand, Content, and Digital Growth